ABSTRACT
Objectives To describe episodic nature of disability among adults living with Long COVID.
Methods We conducted a community-engaged qualitative descriptive study involving online semi-structured interviews and participant visual illustrations. We recruited participants via collaborator community organizations in Canada, Ireland, United Kingdom, and United States.
Participants Adults who self-identified as living with Long COVID. We purposively recruited for diversity in age, gender, race/ethnicity, sexual orientation, and duration since initial COVID-19 infection.
Main Outcome Measure(s) We used a semi-structured interview guide to explore experiences of disability living with Long COVID, specifically health-related challenges and how they were experienced over time. We asked participants to draw their health trajectory and conducted a group-based content analysis.
Results Among the 40 participants, the median age was 39 years (interquartile range: 32, 49); majority were women (63%), white (73%), heterosexual (75%), and living with Long COVID for ≥1 year (83%). Participants described their disability experiences as episodic in nature, characterized by fluctuations in presence and severity of health-related challenges (disability) that may occur both within a day and over the long-term living with Long COVID. They described living with ‘ups and downs’, ‘flare-ups’, and ‘peaks’ followed by ‘crashes’, ‘troughs’, and ‘valleys’, likened to a ‘yo-yo’ ‘rolling hills’, and ‘rollercoaster ride’ with ‘relapsing/remitting’, ‘waxing/waning’, ‘fluctuations’ in health. Drawn illustrations demonstrated variety of trajectories across health dimensions, some more episodic than others. Uncertainty intersected with the episodic nature of disability, characterized as unpredictability of episodes, their length, severity and triggers, and process of long-term trajectory, which had implications on broader health.
Conclusions Among this sample of adults living with Long COVID, experiences of disability were described as episodic, characterized by fluctuating health challenges, which may be unpredictable in nature. Results help to better understand experiences of disability among adults living with Long COVID to inform healthcare and rehabilitation.
KEY MESSAGES
What is already known on this topic: Globally, a growing number of individuals are living with persistent and prolonged signs and symptoms following infection consistent with COVID-19, referred to as Long COVID, Post COVID-19 Condition (PCC) or Post-acute sequelae of SARS-CoV2 (PASC). Individuals living with Long COVID are experiencing a range of symptoms and impairments that impact their ability to carry out day to day activities or engage in social and community life roles.
What this study adds: Disability living with Long COVID was described as episodic, characterized by fluctuations in presence and severity of health related challenges, which may be unpredictable in nature, occurring both within the day, and over the long-term of months and years living with Long COVID.
How this study might affect research, practice or policy: Results will help researchers, healthcare providers, policymakers, employers, and community members to better understand experiences of disability among adults living with Long COVID, to inform future disability measurement, health and rehabilitation care and service delivery, programs and policies for insurance, return to work, and workplace accommodations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Canadian Institutes of Health Research (CIHR) Emerging COVID-19 Research Gaps and Priorities Funding Opportunity (Funding Research Number: GA4-177753) 160 Elgin Street, Ottawa, Ontario, Canada, K1A 0W9). The CIHR had no role in the design of this study and will not have a role during its execution, analyses, interpretation of the data, or decision to submit results. Kelly K. OBrien is supported by a Tier 2 Canada Research Chair in Episodic Disability and Rehabilitation and Angela M. Cheung is supported by a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health from the Canada Research Chairs Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Toronto Health Sciences Research Ethics Board gave ethical approval for this work (Protocol Reference #41749).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email Addresses and ORCID IDs of authors: Kelly K. O’Brien (KKO), PhD, PT: kelly.obrien{at}utoronto.ca, Darren A. Brown (DAB), PT, MClinRes: darren.brown11{at}nhs.net, Kiera McDuff (KMcD), MScPT: kiera.mcduff{at}mail.utoronto.ca, Natalie St. Clair-Sullivan (NSCS), PT, MSc: N.StClair-Sullivan{at}bsms.ac.uk, Patricia Solomon (PS), PhD, PT: solomon{at}mcmaster.ca, Soo Chan Carusone (SCC), PhD: chansy{at}mcmaster.ca, Lisa McCorkell (LMcC): lisa{at}patientledresearch.com, Hannah Wei (HW): hannah.wei{at}patientledresearch.com, Susie Goulding (SG): getaholdofsuzie{at}gmail.com, Margaret O’Hara (MOH): mohara74{at}gmail.com, Catherine Thomson (CT): catherine.thomson9{at}nhs.net, Niamh Roche (NR): Niamh.roche{at}demersal.net, Ruth Stokes (RS): ruthdotstokes2{at}gmail.com, Jaime H. Vera (JHV), MD, PhD: j.vera{at}nhs.net, Kristine M. Erlandson (KME), MD, MS: KRISTINE.ERLANDSON{at}CUANSCHUTZ.EDU, Colm Bergin (CB), MD: CBergin{at}STJAMES.IE, Larry Robinson (LR): Larry.Robinson{at}sunnybrook.ca, Angela M. Cheung (AMC): Angela.Cheung{at}uhn.ca, Brittany Torres (BT), MScPT: brittany.torres{at}utoronto.ca, Lisa Avery (LA): lisa.avery{at}uhnresearch.ca, Ciaran Bannan (CBan): CBannan{at}STJAMES.IE, Richard Harding (RH), PhD: richard.harding{at}kcl.ac.uk;
Data Availability
All data produced in the present work are contained in the manuscript.
